www.contemporarypediatrics.com Open in urlscan Pro
76.76.21.21  Public Scan

Form analysis
2 forms found in the DOM

GET /search

<form method="GET" action="/search" class="flex items-center justify-between w-full"><input type="text" name="searchTerm" placeholder="SEARCH" class="bg-white p-1 rounded-md border-0 w-[80%] text-black" required=""><input type="submit" value="SEARCH"
    class="ml-2 cursor-pointer bg-search-box-button-bg text-search-box-button-text hover:bg-search-box-button-hover-bg hover:text-search-box-button-hover-text ronded rounded-md p-1 font-bold w-[20%]"></form>

GET /search

<form method="GET" action="/search" class="flex items-center justify-between w-full"><input type="text" name="searchTerm" placeholder="SEARCH" class="bg-white p-1 rounded-md border-0 w-[80%] text-black" required=""><input type="submit" value="SEARCH"
    class="ml-2 bg-search-box-button-bg text-search-box-button-text ronded rounded-md p-1 font-bold w-[20%]"></form>

Text Content

 * 

 * 

 * 

 * 

 * 

 * 

 * 

 * 

 * 

 * 

News
All News
PNP Corner
AAP Guidelines
Media
Around the Practice
Cure Connections
Expert Interviews
Insights
Medical World News
Peer Exchange
Peers & Perspectives
Podcasts
Webinars
Puzzler
Publications
Contemporary Pediatrics Journal
Supplements And Featured Publications
CME/CE
Resources
Handouts
Job Board
Sponsored
Conferences
Conference Coverage
Conference Listing
Partnerships
Subscribe
Print Subscription
eNewsletter
Editorial
Editorial Advisory Board
Writer’s Guidelines
Reference Guidelines
Meet the Editors



Spotlight
2022 Best TechChanging Landscape in RSV PreventionDiabetesFood Insecurity and
the Dangers of Infant Formula DilutionGetting into the Roots of Childhood Atopic
DermatitisInfluenzaOpt-Out Chlamydia Screening in Adolescent CareThe Role of the
Healthcare Provider Community in Increasing Public Awareness of RSV in All
InfantsUpdate in Pediatric COVID-19 Vaccines
Clinical
Allergy, Immunology, and ENTCardiologyDermatologyDrug Pipeline NewsEmergency
MedicineEndocrinologyGastroenterologyGynecologyInfectious diseaseMental
HealthNeurologyNutritionOncologyPainPsychiatryRespiratoryRheumatoid
ArthritisSexual HealthView More
News
All News
PNP Corner
AAP Guidelines
Media
Around the Practice
Cure Connections
Expert Interviews
Insights
Medical World News
Peer Exchange
Peers & Perspectives
Podcasts
Webinars
Puzzler
Publications
Contemporary Pediatrics Journal
Supplements And Featured Publications
CME/CE
Resources
Handouts
Job Board
Sponsored
Conferences
Conference Coverage
Conference Listing
Partnerships
Subscribe
Print Subscription
eNewsletter
Editorial
Editorial Advisory Board
Writer’s Guidelines
Reference Guidelines
Meet the Editors

Choose a Specialty
 * Adolescent Medicine
 * Alcohol Abuse
 * Allergies and Infant Formula
 * Allergy, Immunology, and ENT
 * Animal Allergies
 * Autism
 * COVID-19
 * Cardiology
 * Dermatology
 * Developmental/Behavioral Disorders
 * Diabetes
 * Drug Pipeline News
 * Emergency Medicine
 * Endocrinology
 * Gastroenterology
 * Gynecology
 * Infectious disease
 * Influenza
 * Mental Health
 * Neurology
 * Nutrition
 * Nutrition News
 * Obstetrics-Gynecology & Women's Health
 * Oncology
 * Pain
 * Pharmacology
 * Practice Improvement
 * Psychiatry
 * Respiratory
 * Rheumatoid Arthritis
 * Sexual Health
 * Skin Diseases
 * Telemedicine

Advertisement

Adolescent Medicine

| Alcohol Abuse

| Allergies and Infant Formula

| Allergy, Immunology, and ENT

| Animal Allergies

| Autism

| COVID-19

| Cardiology

| Dermatology

| Developmental/Behavioral Disorders

| Diabetes

| Drug Pipeline News

| Emergency Medicine

| Endocrinology

| Gastroenterology

| Gynecology

| Infectious disease

| Influenza

| Mental Health

| Neurology

| Nutrition

| Nutrition News

| Obstetrics-Gynecology & Women's Health

| Oncology

| Pain

| Pharmacology

| Practice Improvement

| Psychiatry

| Respiratory

| Rheumatoid Arthritis

| Sexual Health

| Skin Diseases

| Telemedicine

View All >>
 * Adolescent Medicine
 * Alcohol Abuse
 * Allergies and Infant Formula
 * Allergy, Immunology, and ENT
 * Animal Allergies
 * Autism
 * COVID-19
 * Cardiology
 * Dermatology
 * Developmental/Behavioral Disorders
 * Diabetes
 * Drug Pipeline News
 * Emergency Medicine
 * Endocrinology
 * Gastroenterology
 * Gynecology
 * Infectious disease
 * Influenza
 * Mental Health
 * Neurology
 * Nutrition
 * Nutrition News
 * Obstetrics-Gynecology & Women's Health
 * Oncology
 * Pain
 * Pharmacology
 * Practice Improvement
 * Psychiatry
 * Respiratory
 * Rheumatoid Arthritis
 * Sexual Health
 * Skin Diseases
 * Telemedicine

SPOTLIGHT -

Influenza

| Diabetes

| Changing Landscape in RSV Prevention

| Food Insecurity and the Dangers of Infant Formula Dilution

| Getting into the Roots of Childhood Atopic Dermatitis

| Opt-Out Chlamydia Screening in Adolescent Care

| The Role of the Healthcare Provider Community in Increasing Public Awareness
of RSV in All Infants

| Update in Pediatric COVID-19 Vaccines

| 2022 Best Tech



LATEST NEWS

Contemporary Pediatrics week in review: Infant mortality rates, FDA approvals,
and more
By Joshua Fitch, Editor

November 3rd 2023

Review some of the top stories from the Contemporary Pediatrics website over the
last week, and catch up on anything you may have missed.

Most-viewed articles on Contemporary Pediatrics from August to October, 2023
By Joshua Fitch, Editor

November 3rd 2023

Take a look back at some of the top-performing stories from Contemporary
Pediatrics with this review article. Stories featured in this article are
re-capped and directly link to our most-viewed articles from August through
October 2023.

FDA broadens abatacept usage to include psoriatic arthritis patients aged 2
years and older
By Lana Pine

November 2nd 2023

The FDA has approved abatacept (Orencia) for patients aged ≥2 years with active
psoriatic arthritis (PsA), a condition causing joint damage in pediatric
patients, offering a new treatment option for juvenile PsA, benefiting young
patients, caregivers, and healthcare professionals.

Infant mortality rate sees first year-to-year increase in 2 decades
By Joshua Fitch, Editor

November 2nd 2023

For the first time since 2001 to 2002, a year-to-year increase of the infant
mortality rate was observed in the United States from 2021 to 2022. The
provisional 20,538 infant deaths reported in 2022 were a 3% increase compared to
2021.

Follow up visits occur in half of children with acute bronchiolitis under 2
years of age
By Tim Smith

November 1st 2023

The importance of follow-up meetings for youth patients discharged from
emergency departments is highlighted by new research.

Latest Videos
Implementing early autism screening into your practice

Steven Selbst, MD, discusses ED trends, highlights mental health admissions

Negotiating to get paid what you deserve

Implementing social and emotional screening tools in your practice

Young athletes, social media, and body image issues

Update on allergy prevention and food introduction

Removing false labels of penicillin allergy from pediatric medical records

Breaking down toddler formulas and the confusion associated with naming,
labeling

Will FDA approved phentolamine ophthalmic solution 0.75% eye drops impact
pediatric care?

How the pediatrician can play a role in limiting school avoidance

School avoidance trends and the negative effects associated with excessive
missed days

The current state of transgender reproductive care in the United States

Developing biomarkers for gut and neurological, cognitive functioning
associations in children

Bridging the Gap for T1D Management

Investigational Approaches for Treating T1D

How are gut microbiomes and pediatric neurological, cognitive conditions being
linked?

Podcasts
Demystifying Infant Formula

What's going on with polio, monkeypox, and COVID-19

Having "the talk" with teen patients

Meet the Board: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI

Meet the board: Jessica L. Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN

The Role of the Healthcare Provider Community in Increasing Public Awareness of
RSV in All Infants

Report Urges Increased Role of Health Community in Increasing Awareness of RSV
Disease

Addressing atypical anorexia: Part 3

Addressing atypical anorexia: Part 2

Meet the board: Michael S. Jellinek, MD

Continuing Medical Education

In-Person EventCME

21st Annual School of Breast Oncology

Register Now!




In-Person + Virtual EventCME

Enjoy these CME sessions at AAO 2023

Register Now!




CourseCME

Oncology Consultations®: Leveraging Clinical Data and Trials to Inform Treatment
for Patients with PV

View More




Live Webcast RegistrationCME

Reflective Case-Based Oncology Collective: Real-World Applications of Novel
Therapies Across TNBC and Addressing Disparities in Care

View More




In-Person EventCME,CNE,CPE

41st Annual CFS®: Innovative Cancer Therapy for Tomorrow®

Register Now!




Hybrid MeetingCME

C.R.U. Eye Symposium (Current, Relevant, Useful)

11/10/2023-11/12/2023

Register Now!




Archived WebcastCME,CNE

2022 4th Annual International Congress on the Future of Neurology

View More




In-Person EventCME,CNE

18th Annual New York Lung Cancers Symposium®

Register Now!






ALL NEWS



Dupilumab demonstrates efficacy in children with eosinophilic esophagitis for up
to 1 year

By Joshua Fitch, Editor
November 1st 2023


Longer-term data was recently released for dupilumab as a treatment for
eosinophilic esophagitis (EoE) in children aged 1 to 11 years, demonstrating a
similar safety and efficacy profile for up to 1 year of treatment. A
supplemental Biologic License Application was accepted by the FDA in September
2023 with a Priority Review designation.



Caregiver-administered influenza vaccine’s Biologics License Application
accepted by FDA

By Joshua Fitch, Editor
October 31st 2023


A usability study demonstrated that individuals older than 18 years could
self-administer the intranasal treatment or administer it to eligible patients
aged 2 to 49 years, when given instructions and no additional guidance.



Gene therapy improves auditory response for child with profound genetic hearing
loss

By Joshua Fitch, Editor
October 31st 2023


A child with profound genetic hearing loss was dosed with an investigational
otoferlin gene therapy (DB-OTO), the first patient dosed in a phase 1/2 trial
evaluating the treatment. The child experienced improved auditory response at
week 6 with no concerning safety signals.



FDA approves vamorolone to treat Duchenne muscular dystrophy

By Joshua Fitch, Editor
October 30th 2023


Vamorolone, oral suspension 40 mg / ml, has been approved by the FDA to treat
Duchenne muscular dystrophy (DMD) in patients aged 2 years and up, according to
Santhera Pharmaceuticals.



Contemporary Pediatrics week in review: Nirsevimab recommendation, AAP updates,
and more

By Morgan Petronelli, Managing Editor
October 27th 2023


Review some of the top stories from the Contemporary Pediatrics website over the
last week, and catch up on anything you may have missed.



Discussing software that helps track progress after an autism diagnosis

By Joshua Fitch, Editor
October 27th 2023


In this interview with Contemporary Pediatrics®, Lauren Lanzon, MSW, MA, BCBA,
clinical trainer, Carolina Behavioral Innovations, explains how technology and
software is helping families following an autism diagnosis in their child.



Combination influenza and COVID-19 vaccine program demonstrates positive phase ½
results

By Joshua Fitch, Editor
October 26th 2023


The combination vaccine candidates demonstrated a safety profile consistent with
Pfizer’s COVID-19 vaccine. A phase 3 trial is anticipated to commence in the
coming months, according to a press release from Pfizer.



CDC recommends nirsevimab be prioritized for highest-risk infants amid limited
availability

By Joshua Fitch, Editor
October 26th 2023


The Centers for Disease Control and Prevention is advising providers to
prioritize 100 mg doses of nirsevimab, a monoclonal antibody FDA-approved to
prevent respiratory syncytial virus (RSV), for infants at the highest risk of
severe RSV disease.



Steven Selbst, MD, discusses receiving Jim Seidel Distinguished Service Award

By Joshua Fitch, Editor
October 23rd 2023


"I was honored this year, really truly honored, to receive the Jim Seidel
Distinguished Service Award for the section of emergency medicine," said
Contemporary Pediatrics Editorial Advisory Board member Steven Selbst, MD at the
2023 American Academy of Pediatrics National Conference & Exhibition.



Lessons in asking patients' gender identity and sexual orientation

By Morgan Petronelli, Managing Editor
October 23rd 2023


A recent study presented at the 2023 American Academy of Pediatrics National
Conference & Exhibition evaluated how clinicians can ask patients' sexual
orientation and gender identity for EHR documentation.



Delta-8 accessibility to minors online

By Morgan Petronelli, Managing Editor
October 23rd 2023


In recent research highlighted at the 2023 American Academy of Pediatrics
National Conference & Exhibition, investigators sought to evaluate the level of
access and marketing of Delta-8 THC (D8) to minors online.



How culinary knowledge can impact physical, mental and environmental health

By Joshua Fitch, Editor
October 23rd 2023


In this Contemporary Pediatrics interview, Michelle Loy, MD, FAAP, recaps her
session, "Culinary Medicine: Using Food for Physical, Mental, and Environmental
Health" presented at the 2023 American Academy of Pediatrics National Conference
& Exhibition in Washington DC.



How childhood sexual abuse affects adult survivors

By Morgan Petronelli, Managing Editor
October 22nd 2023


Varsha M. Puri, DO, shares her latest research on how childhood sexual abuse and
incest affect experiences and behaviors in adulthood, which was presented in a
poster session at the 2023 American Academy of Pediatrics National Conference &
Exhibition.



RSV: 1 year post-tripledemic emergency department update

By Joshua Fitch, Editor
October 22nd 2023


Steven Selbst, MD, provides a quick update on what he has noticed in his
hospital when it comes to RSV-associated emergency department visits and how
they compare to this time last year, during the "tripledemic." This interview
was conducted at the 2023 American Academy of Pediatrics National Conference and
Exhibition in Washington DC.



Evaluating risk of suicide and limiting youth access to firearms

By Joshua Fitch, Editor
October 22nd 2023


At the 2023 American Academy of Pediatrics National Conference & Exhibition,
Eric J. Sigel, MD, FAAP, professor of pediatrics, University of Colorado School
of Medicine, explains his session "Suicide and Gun Violence: What We Know, What
We Can Do."



High-powered magnet ingestion and socioeconomic disparities

By Morgan Petronelli, Managing Editor
October 22nd 2023


Leah K. Middleberg, MD, FAAP, explains her research on magnet ingestion and
socioeconomic disparities, which was recently presented at the 2023 American
Academy of Pediatrics National Conference & Exhibition.



Paternal depression associated with adverse childhood experiences in children

By Morgan Petronelli, Managing Editor
October 21st 2023


In this Q&A, Kristine H. Schmitz, MD, explains her team's recent research on
paternal depression and adverse childhood experiences during the 2023 American
Academy of Pediatrics National Conference & Exhibition.



Preterm infant HRQOL: Long-term impacts and determinants

By Morgan Petronelli, Managing Editor
October 21st 2023


A recent study was highlighted at the 2023 American Academy of Pediatrics
National Conference & Exhibition that shed light on the long-term impact of very
preterm birth on the health-related quality of life (HRQOL) of infants and
identified key determinants.



Navigating a complex case of pediatric COVID-19 with immunomodulatory therapies

By Joshua Fitch, Editor
October 21st 2023


Eculizumab and anakinra should be considered in critically ill patients with
severe infections that require immunomodulating therapies for life-threatening
dysregulation, according to a poster session at the 2023 American Academy of
Pediatrics National Conference & Exhibition.



CRL issued for dupilumab in chronic spontaneous urticaria

By Kevin Kunzmann
October 21st 2023


The Complete Response Letter (CRL) is based on additional efficacy data required
by the FDA, according to Sanofi and Regeneron.



IDP-126 topical gel approved by FDA to treat acne in patients 12 years and up

By Joshua Fitch, Editor
October 21st 2023


The topical gel is the first and only FDA-approved triple-combination,
fixed-dose topical treatment for acne, and is set to be available in the first
quarter of 2024, according to Bausch Health Companies Inc.



Nipocalimab: A promising intervention for early-onset severe hemolytic disease
of the fetus and newborn?

By Morgan Petronelli, Managing Editor
October 21st 2023


Nipocalimab (Janssen) may be promising for the antenatal and postnatal
management of fetal anemia in pregnancies at high risk for EOS-HDFN , according
to data from the phase 2 UNITY study presented at the 2023 American Academy of
Pediatrics National Conference & Exhibition



FDA approves expanded use of vosoritide injection for children under age 5 with
achondroplasia 

By Joshua Fitch, Editor
October 20th 2023


In a phase 2 clinical trial, the safety and efficacy of vosoritide was similar
in children aged younger than 5 years to those older than 5 years. 



FDA approves pentavalent meningococcal vaccine for patients aged 10 to 25 years

By Joshua Fitch, Editor
October 20th 2023


The FDA approval could simplify meningococcal vaccine schedules while providing
broad serogroup coverage.



Safe sleep practices among parents

By Morgan Petronelli, Managing Editor
October 20th 2023


Authors of a study highlighted at the 2023 American Academy of Pediatrics
National Conference & Exhibition suggest psychosocial factors are significant
contributors to parents' decisions regarding safe sleep


See All News >
Advertisement

Recent Content

Contemporary Pediatrics week in review: Infant mortality rates, FDA approvals,
and more



Most-viewed articles on Contemporary Pediatrics from August to October, 2023



FDA broadens abatacept usage to include psoriatic arthritis patients aged 2
years and older



Infant mortality rate sees first year-to-year increase in 2 decades

View More Recent Content
Advertisement

Advertisement

x

About Us
Advertise
Contact Us
Job Board
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777



© 2023 MJH Life Sciences

All rights reserved.